Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT. (Q36326173)

13 August 2017

Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT. (English)

1 reference

13 August 2017

1 reference

S Tokunaga

1

1 reference

13 August 2017

M Koda

2

1 reference

13 August 2017

T Matono

3

1 reference

13 August 2017

T Sugihara

4

1 reference

13 August 2017

T Nagahara

5

1 reference

13 August 2017

M Ueki

6

1 reference

13 August 2017

Y Murawaki

7

1 reference

13 August 2017

S Kakite

8

1 reference

13 August 2017

E Yamashita

9

1 reference

13 August 2017

language of work or name

English

0 references

publication date

8 March 2011

1 reference

British Journal of Radiology

13 August 2017

1 reference

13 August 2017

85

1 reference

13 August 2017

1014

1 reference

13 August 2017

745-752

1 reference

describes a project that uses

13 August 2017

magnetic resonance imaging

1 reference

Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran--feasibility study.

inferred from title

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Radiofrequency ablation of hepatic tumors: lessons learned from 3000 procedures

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Spectrum of CT findings after radiofrequency ablation of hepatic tumors.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Imaging appearances following thermal ablation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Assessment of tumor response on MR imaging after locoregional therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Relaxation effects of clustered particles

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.

29 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1259%2FBJR%2F64518148

Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1259%2FBJR%2F64518148

Clinicopathologic study of small hepatocellular carcinoma with microscopic satellite nodules to determine the extent of tumor ablation by local therapy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474088

Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography; comparison with virtual sonography with magnetic navigation

22 September 2018

1 reference

12 December 2020

Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features

1 reference

12 December 2020

Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver

1 reference

12 December 2020

Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide

1 reference

12 December 2020

Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading

1 reference

12 December 2020

Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors

1 reference

12 December 2020

Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma

1 reference

12 December 2020

Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment

1 reference

12 December 2020

Identifiers

DOI

10.1259/BJR/64518148

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

21385915

1 reference